Cleared Traditional

K051194 - BD ONECATH PERIPHERALLY INSERTED CENTRA...

K051194 is an FDA 510(k) clearance for BD ONECATH PERIPHERALLY INSERTED CENTRA..., manufactured by Becton, Dickinson & CO. The device is a Class 2 General Hospital device with product code LJS cleared through the Traditional 510(k) pathway after a 76-day FDA review.

K051194 · Becton, Dickinson & CO · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2005
Decision
76d
Days
Class 2
Risk

K051194 is an FDA 510(k) clearance for the BD ONECATH PERIPHERALLY INSERTED CENTRAL CATHETER, MODELS 384647, 384667, 384.... Classified as Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days (product code LJS), Class II - Special Controls.

Submitted by Becton, Dickinson & CO (Sandy, US). The FDA issued a Cleared decision on July 25, 2005 after a review of 76 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5970 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Becton, Dickinson & CO devices

FDA 510(k) Submission Details - K051194

510(k) Number K051194 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 10, 2005
Decision Date July 25, 2005
Days to Decision 76 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
53d faster than avg
Panel avg: 129d · This submission: 76d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJS Device Classification - Class 2, Special Controls

Product Code LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5970
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days

All 193
Devices cleared under the same product code (LJS) and FDA review panel - the closest regulatory comparables to K051194.
PRO-LINE CT POWER INJECTABLE CVC, MODELS CTLINES5S, CTLINE6D
K053345 · Medcomp · Mar 2006
POWERPICC, POLY PER-Q-CATH, 6 FR TL POLY PER-Q-CATH, POWER HOHN AND POWER LINE
K051991 · C.R. Bard, Inc. · Oct 2005
VYGON NUTRILINE CATHETERS
K051690 · Vygon Corp. · Aug 2005
TURBO-FLO PICC
K041849 · Cook, Inc. · Jul 2005
6 FR FL POWERHOHN AND POWERLINE CATHETER
K051417 · C.R. Bard, Inc. · Jun 2005
6 FR DL POWERPICC CATHETER
K050931 · C.R. Bard, Inc. · Jun 2005